logo
logo
AI

Discover the World’s Fastest Business Insights

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Gross-Wen Technologies Closes Oversubscribed $6.5 Million Investment

Gross-Wen Technologies Closes Oversubscribed $6.5 Million Investment

08/20/21, 2:14 PM
Money raised
$6.5 million
Gross-Wen Technologies, a leading algae-based wastewater treatment company based in rural Slater, Iowa, is pleased to announce the closing of its Series A investment round. ISA Ventures and Iowa Farm Bureau's Rural Vitality Fund co-led this $6.5 million Series A investment in Gross-Wen Technologies, along with Next Level Ventures, Mid-American Angels, Ankeny Angels, Ag Startup Engine, Oman Ventures, and 1330 Investments. Gross-Wen Technologies has a patented wastewater treatment technology that uses algae to clean wastewater.

Company Info

Company
Gross Wen Technologies
Additional Info
GWT is a wastewater treatment technology company which uses algae instead of bacteria or chemicals to recover nitrogen and phosphorus from wastewater. Algae is considered the most sustainable way to treat wastewater. This is because during the treatment process algae is consuming CO2 from the atmosphere, then the CO2 containing algae is used as a slow-release fertilizer. What makes GWT unique is their algae-based treatment solution, called the revolving algal biofilm system (RAB), which is considered by many experts as the top algae treatment system in the world (6 issued patents). The company was founded by Dr. Martin Gross and Dr. Zhiyou Wen and is based on a technology they developed at Iowa State University. For more information: algae.com
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.